Related Experiment Video
Updated: Sep 13, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.7K
Recent Advances in Medications for Reducing Lipid Levels.
Xin Hu1,2, Xin Jia1, Xiaoming Wang1
1From the Department of Geriatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.
Cardiology in Review
|August 1, 2025
Summary
Novel therapies targeting dyslipidemia, including PCSK9 inhibitors and gene silencing, offer potent lipid reduction. These advancements provide new hope for preventing atherosclerotic cardiovascular diseases (ASCVD).
Area of Science:
- Cardiology
- Pharmacology
- Biotechnology
Background:
- Dyslipidemia is a primary risk factor for atherosclerotic cardiovascular diseases (ASCVD).
- Traditional therapies like statins have limitations in managing lipid levels effectively.
Purpose of the Study:
- To provide an updated overview of emerging lipid-lowering therapies.
- To focus on novel therapeutic targets and biotechnological approaches for dyslipidemia management.
Main Methods:
- Review of recent clinical research on novel lipid-lowering agents.
- Analysis of emerging targets such as PCSK9, angiopoietin-like 3, and APOC3.
- Evaluation of biotechnological approaches including monoclonal antibodies, ASOs, and RNA interference.
Main Results:
- Emerging therapies demonstrate potent lipid-lowering efficacy.
- Novel agents show promising results in clinical trials for managing dyslipidemia.
- These therapies offer new mechanisms of action beyond traditional treatments.
Conclusions:
- Advancements in lipid-lowering therapies are transforming cardiovascular disease prevention.
- Innovative treatments offer improved efficacy and new hope for patients at risk of ASCVD.
- The field is rapidly evolving, promising better patient outcomes in dyslipidemia management.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
875
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
875
01:26Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
01:30Heart Failure V: Medical Management
25
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
25
01:26Coronary Artery Disease IV: Preventive Measures
35
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
35
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
40
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
40
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29